Information submitted by users of biologics shall be treated as confidential information to the extent that the release thereof will divulge the contents or formulation of such product.
02 N.C. Admin. Code 52G .0303
Eff. April 1, 1984;
Readopted Eff. July 1, 2019.
Eff. April 1, 1984.